A delegation from the Health Committee of the Parliament of Catalonia visited the HIPRA Campus this Friday, located in Aiguaviva (Girona), with the aim of learning first-hand about the biotech company’s activity, its commitment to innovation in human and animal health, and its contribution to strengthening the Catalan and European healthcare ecosystem.
The delegation was led by Carles Campuzano i Canadés (GP Esquerra Republicana de Catalunya), Chair of the Committee, accompanied by Maite Selva Huertas (GP Junts per Catalunya), Secretary; Sara Jaurrieta Guarner (GP Partit dels Socialistes de Catalunya), Spokesperson; and Eva García Rodríguez (GP Partit Popular de Catalunya).
During the visit, members of the Committee held a meeting with HIPRA experts, during which the company’s evolution, growth strategy, and strong commitment to the One Health approach were presented, integrating human and animal health as key levers to address major global health challenges.
Throughout the day, the delegation learned in detail about the projects that HIPRA is developing in the fields of vaccines and biotechnology, as well as the activity of GoodGut, a biotechnology company specialising in digestive health that is part of the group. The parliamentary representatives also visited the R&D and production facilities of the HIPRA Campus, conceived as a benchmark space for research, technological development, and the attraction of highly qualified talent.
HIPRA highlighted the role of the Campus as a driver of innovation, competitiveness, and territorial development, as well as its contribution to strengthening strategic autonomy in health and response capacity to future health emergencies, in close collaboration with public and private institutions.
The company thanked the Health Committee for its interest and underscored the importance of maintaining an open and constructive dialogue with institutional representatives, which is key to continuing to promote a growth model based on knowledge, science, and public-private collaboration.
